Business
CORRECTION: THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President
CORRECTION: THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President.
About this update from Thc Farmaceuticals, Inc
[{"type":"text","content":" Normal 0 false false false EN-US JA X-NONE /* Style Definitions */table.MsoNormalTable\t{mso-style-name:\"Table Normal\";\tmso-tstyle-rowband-size:0;\tmso-tstyle-colband-size:0;\tmso-style-noshow:yes;\tmso-style-priority:99;\tmso-style-parent:\"\";\tmso-padding-alt:0in 5.4pt 0in 5.4pt;\tmso-para-margin:0in;\tmso-para-margin-bottom:.0001pt;\tmso-pagination:widow-orphan;\tfont-size:10.0pt;\tfont-family:\"Times New Roman\";\tborder:none;}THC Farmaceuticals, Inc. (OTCQB:CBDG): today announcedthat Ed Rosenthal, a noted horticulturist, author and publisher is joining CBDGas President of the Company, officially taking up his duties June 15th,2015. Mr. Rosenthal has also agreed to serve as a director of CBDG uponappointment.Rosenthal is anoted researcher and writer who has specialized in marijuana studies for morethan 35 years. One of his discoveries was identifying terpenes as importantcomponents of marijuana, which he chronicled in his work “Big Book of Buds Vol.3”. Properties of the marijuana plant includes the psychoactive THC, themedically promising cannabinoids (CBD’s) and Terpenes, whose cumulative effectwas later identified by Dr. Raphael Mechoulum, Dean of marijuana researchers,as “The Entourage Effect”. Rosenthalplans to lead a team of researchers in developing targeted intermediaryphytochemical combinations that can be used in production of both cannabinoidand non-cannabinoid based products.Rosenthalestimates that the first products based on this research will complete trialwithin six months and will be on store shelves within a year. He stated,“I appreciate the opportunity to lead this research program to develop new andbetter plant based medicines”This inclusion of Ed Rosenthal to THC Farmaceuticalsbrings to the company the knowledge base of one of the cannabis industries’foremost horticulturist and activists. As an industry leader and cannabisexpert, Mr. Rosenthal will help guide the company’s expansion into cannabis andcannabis related business. Chief Executive Officer and Former US Senator Mike Gravelstated, “Ed is incredibly knowledgeable; his experience in and connectionwith the cannabis industry is unparalleled. We already had lofty expectationsat THC Farmaceuticals and we’re happy to have secured Rosenthal’sservices and are looking forward to working closely with the research team heis assembli...